• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾小球肾炎:免疫发病机制与免疫治疗。

Glomerulonephritis: immunopathogenesis and immunotherapy.

机构信息

Division of Nephrology, Department of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Munich, Germany.

Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC, Australia.

出版信息

Nat Rev Immunol. 2023 Jul;23(7):453-471. doi: 10.1038/s41577-022-00816-y. Epub 2023 Jan 12.

DOI:10.1038/s41577-022-00816-y
PMID:36635359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9838307/
Abstract

'Glomerulonephritis' (GN) is a term used to describe a group of heterogeneous immune-mediated disorders characterized by inflammation of the filtration units of the kidney (the glomeruli). These disorders are currently classified largely on the basis of histopathological lesion patterns, but these patterns do not align well with their diverse pathological mechanisms and hence do not inform optimal therapy. Instead, we propose grouping GN disorders into five categories according to their immunopathogenesis: infection-related GN, autoimmune GN, alloimmune GN, autoinflammatory GN and monoclonal gammopathy-related GN. This categorization can inform the appropriate treatment; for example, infection control for infection-related GN, suppression of adaptive immunity for autoimmune GN and alloimmune GN, inhibition of single cytokines or complement factors for autoinflammatory GN arising from inborn errors in innate immunity, and plasma cell clone-directed or B cell clone-directed therapy for monoclonal gammopathies. Here we present the immunopathogenesis of GN and immunotherapies in use and in development and discuss how an immunopathogenesis-based GN classification can focus research, and improve patient management and teaching.

摘要

肾小球肾炎(GN)是一组描述由肾脏过滤单位(肾小球)炎症引起的异质性免疫介导疾病的术语。这些疾病目前主要基于组织病理学损伤模式进行分类,但这些模式与它们不同的病理机制并不吻合,因此无法提供最佳的治疗方法。相反,我们建议根据其免疫发病机制将 GN 疾病分为五类:感染相关 GN、自身免疫性 GN、同种免疫性 GN、自身炎症性 GN 和单克隆丙种球蛋白病相关 GN。这种分类可以为适当的治疗提供信息;例如,感染相关 GN 需要控制感染,自身免疫性 GN 和同种免疫性 GN 需要抑制适应性免疫,由先天免疫中固有免疫缺陷引起的自身炎症性 GN 需要抑制单一细胞因子或补体因子,单克隆丙种球蛋白病需要浆细胞克隆定向或 B 细胞克隆定向治疗。在这里,我们介绍 GN 的免疫发病机制和已使用及正在开发中的免疫疗法,并讨论基于免疫发病机制的 GN 分类如何能够聚焦研究,改善患者管理和教学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/5e162bc72bac/41577_2022_816_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/dafabc497467/41577_2022_816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/cf0eac9f74f5/41577_2022_816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/cdef9afac431/41577_2022_816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/5e162bc72bac/41577_2022_816_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/dafabc497467/41577_2022_816_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/cf0eac9f74f5/41577_2022_816_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/cdef9afac431/41577_2022_816_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35db/9838307/5e162bc72bac/41577_2022_816_Fig4_HTML.jpg

相似文献

1
Glomerulonephritis: immunopathogenesis and immunotherapy.肾小球肾炎:免疫发病机制与免疫治疗。
Nat Rev Immunol. 2023 Jul;23(7):453-471. doi: 10.1038/s41577-022-00816-y. Epub 2023 Jan 12.
2
The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC).根据发病机制、活动度和慢性度分类的五种肾小球肾炎(GN-AC)。
Nephrol Dial Transplant. 2023 Nov 8;38(Supplement_2):ii3-ii10. doi: 10.1093/ndt/gfad067.
3
C3 glomerulonephritis associated with monoclonal gammopathy: a case series.C3 肾小球肾炎伴单克隆丙种球蛋白血症:病例系列。
Am J Kidney Dis. 2013 Sep;62(3):506-14. doi: 10.1053/j.ajkd.2013.02.370. Epub 2013 Apr 26.
4
Complement dysregulation in glomerulonephritis.补体失调与肾小球肾炎。
Semin Immunol. 2019 Oct;45:101331. doi: 10.1016/j.smim.2019.101331. Epub 2019 Nov 9.
5
Etiology-based diagnostic approach to proliferative glomerulonephritis.基于病因的增生性肾小球肾炎的诊断方法。
Am J Kidney Dis. 2014 Apr;63(4):561-6. doi: 10.1053/j.ajkd.2013.11.019. Epub 2013 Dec 31.
6
Glomerulonephritis.肾小球肾炎。
Pediatr Rev. 2023 Sep 1;44(9):498-512. doi: 10.1542/pir.2021-005259.
7
Cytokines in glomerulonephritis.肾小球肾炎中的细胞因子
Semin Nephrol. 2007 May;27(3):275-85. doi: 10.1016/j.semnephrol.2007.02.002.
8
Basic and translational concepts of immune-mediated glomerular diseases.免疫介导性肾小球疾病的基础与转化医学概念。
J Am Soc Nephrol. 2012 Mar;23(3):381-99. doi: 10.1681/ASN.2011030304. Epub 2012 Jan 26.
9
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.增生性肾小球肾炎伴单克隆免疫球蛋白沉积:肾内科医师视角。
Nephrol Dial Transplant. 2021 Jan 25;36(2):208-215. doi: 10.1093/ndt/gfz176.
10
Glomerulonephritis in Animal Models and Human Medicine: Discovery, Pathogenesis, and Diagnostics.动物模型和人类医学中的肾小球肾炎:发现、发病机制与诊断
Toxicol Pathol. 2018 Dec;46(8):898-903. doi: 10.1177/0192623318800714. Epub 2018 Oct 3.

引用本文的文献

1
Intraglomerular Inflammation as a Guide for Mycophenolate Mofetil-Based Treatment in IgA Nephropathy.肾小球内炎症作为IgA肾病中以霉酚酸酯为基础治疗的指导
Diagnostics (Basel). 2025 Aug 20;15(16):2101. doi: 10.3390/diagnostics15162101.
2
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.原发性膜性肾病患者中抗利妥昔单抗抗体的发生情况及临床结局
Kidney Int Rep. 2025 May 6;10(8):2621-2629. doi: 10.1016/j.ekir.2025.04.059. eCollection 2025 Aug.
3
Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials.

本文引用的文献

1
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management.妊娠期肾小球疾病:临床管理实用建议
Kidney Int. 2023 Feb;103(2):264-281. doi: 10.1016/j.kint.2022.10.029. Epub 2022 Dec 5.
2
Efficacy of Corticosteroids in Infection-Related Glomerulonephritis-A Randomized Controlled Trial.皮质类固醇在感染相关性肾小球肾炎中的疗效——一项随机对照试验
Kidney Int Rep. 2022 Aug 4;7(10):2160-2165. doi: 10.1016/j.ekir.2022.07.163. eCollection 2022 Oct.
3
Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy.
雷公藤多苷作为免疫调节剂联合传统免疫抑制剂在免疫介导性肾脏疾病中的疗效:一项随机对照试验的系统评价和荟萃分析
Front Pharmacol. 2025 Jul 11;16:1525482. doi: 10.3389/fphar.2025.1525482. eCollection 2025.
4
Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets.自身免疫性疾病:分子发病机制与治疗靶点
MedComm (2020). 2025 Jun 16;6(7):e70262. doi: 10.1002/mco2.70262. eCollection 2025 Jul.
5
Association between immune cell subtypes and membranous nephropathy: A bidirectional Mendelian randomization study.免疫细胞亚型与膜性肾病之间的关联:一项双向孟德尔随机化研究。
Medicine (Baltimore). 2025 Jun 6;104(23):e42774. doi: 10.1097/MD.0000000000042774.
6
Prevalence of Proteinuria in Dogs With Immune-Mediated Disease.免疫介导性疾病犬蛋白尿的患病率
J Vet Intern Med. 2025 Jul-Aug;39(4):e70162. doi: 10.1111/jvim.70162.
7
Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide.布地奈德治疗的IgA肾病患者蛋白尿进展中尿生物标志物的预后价值
Medicina (Kaunas). 2025 Apr 26;61(5):807. doi: 10.3390/medicina61050807.
8
Vitamin D Deficiency and the Clinical Outcomes of Calcimimetic Therapy in Dialysis Patients: A Population-Based Study.维生素D缺乏与拟钙剂治疗对透析患者临床结局的影响:一项基于人群的研究。
Nutrients. 2025 Apr 30;17(9):1536. doi: 10.3390/nu17091536.
9
Extracellular Vesicles in Renal Inflammatory Diseases: Revealing Mechanisms of Extracellular Vesicle-Mediated Macrophage Regulation.肾脏炎症性疾病中的细胞外囊泡:揭示细胞外囊泡介导的巨噬细胞调节机制
Int J Mol Sci. 2025 Apr 12;26(8):3646. doi: 10.3390/ijms26083646.
10
Magnetic resonance imaging of renal oxygenation.肾脏氧合的磁共振成像。
Nat Rev Nephrol. 2025 Apr 23. doi: 10.1038/s41581-025-00956-z.
神经轴索导向因子 G1 是原发性膜性肾病的一个新的靶抗原。
J Am Soc Nephrol. 2022 Oct;33(10):1823-1831. doi: 10.1681/ASN.2022050608. Epub 2022 Aug 19.
4
Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice.新月体形成的肾祖细胞向足细胞分化可减轻小鼠严重肾小球肾炎。
Sci Transl Med. 2022 Aug 10;14(657):eabg3277. doi: 10.1126/scitranslmed.abg3277.
5
C3 glomerulopathy: Understanding an ultra-rare complement-mediated renal disease.C3 肾小球病:认识一种超罕见的补体介导性肾脏疾病。
Am J Med Genet C Semin Med Genet. 2022 Sep;190(3):344-357. doi: 10.1002/ajmg.c.31986. Epub 2022 Jun 23.
6
Monoclonal antibody-based therapies for Waldenström's macroglobulinemia.用于华氏巨球蛋白血症的单克隆抗体疗法。
Leuk Res Rep. 2022 May 6;17:100324. doi: 10.1016/j.lrr.2022.100324. eCollection 2022.
7
Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.自身免疫性肾小球肾炎中补体途径激活的比较
Kidney Int Rep. 2022 Feb 14;7(5):1027-1036. doi: 10.1016/j.ekir.2022.02.002. eCollection 2022 May.
8
Proteasome inhibition: the dawn of novel therapies in multiple myeloma.蛋白酶体抑制:多发性骨髓瘤新型疗法的曙光
Haematologica. 2022 May 1;107(5):1018-1019. doi: 10.3324/haematol.2022.280857.
9
TLR7 gain-of-function genetic variation causes human lupus.TLR7 获得性功能遗传变异导致人类狼疮。
Nature. 2022 May;605(7909):349-356. doi: 10.1038/s41586-022-04642-z. Epub 2022 Apr 27.
10
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.JAK 抑制剂阻断 COVID-19 细胞因子诱导的肾小球细胞 JAK/STAT/APOL1 信号通路及人肾类器官中的足细胞病变。
JCI Insight. 2022 Jun 8;7(11):e157432. doi: 10.1172/jci.insight.157432.